These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28531845)

  • 1. Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria.
    Du Y; Chen G; Zhang X; Yu C; Cao Y; Cui L
    Int Immunopharmacol; 2017 Jul; 48():219-230. PubMed ID: 28531845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artesunate-erythropoietin combination for murine cerebral malaria treatment.
    Bienvenu AL; Ferrandiz J; Kaiser K; Latour C; Picot S
    Acta Trop; 2008 May; 106(2):104-8. PubMed ID: 18359468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S1P is associated with protection in human and experimental cerebral malaria.
    Finney CA; Hawkes CA; Kain DC; Dhabangi A; Musoke C; Cserti-Gazdewich C; Oravecz T; Liles WC; Kain KC
    Mol Med; 2011; 17(7-8):717-25. PubMed ID: 21556483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin protects against murine cerebral malaria through actions on host cellular immunity.
    Wei X; Li Y; Sun X; Zhu X; Feng Y; Liu J; Jiang Y; Shang H; Cui L; Cao Y
    Infect Immun; 2014 Jan; 82(1):165-73. PubMed ID: 24126529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-seq-based transcriptome analysis of the anti-inflammatory effect of artesunate in the early treatment of the mouse cerebral malaria model.
    Wang Q; Tang Y; Pan Z; Yuan Y; Zou Y; Zhang H; Guo X; Guo W; Huang X; Wu Z; Li C; Xu Q; Song J; Deng C
    Mol Omics; 2022 Sep; 18(8):716-730. PubMed ID: 35960011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain.
    Clemmer L; Martins YC; Zanini GM; Frangos JA; Carvalho LJ
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1383-90. PubMed ID: 21220531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of artesunate combined with Atractylodes lancea or Prabchompoothaweep remedy extracts as adjunctive therapy for the treatment of cerebral malaria.
    Plirat W; Chaniad P; Phuwajaroanpong A; Konyanee A; Viriyavejakul P; Septama AW; Punsawad C
    BMC Complement Med Ther; 2023 Sep; 23(1):332. PubMed ID: 37730604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria.
    Miranda AS; Brant F; Rocha NP; Cisalpino D; Rodrigues DH; Souza DG; Machado FS; Rachid MA; Teixeira AL; Campos AC
    Malar J; 2013 Nov; 12():388. PubMed ID: 24180288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylhydrazine administration accelerates the development of experimental cerebral malaria.
    Zhu X; Liu J; Feng Y; Pang W; Qi Z; Jiang Y; Shang H; Cao Y
    Exp Parasitol; 2015 Sep; 156():1-11. PubMed ID: 26005191
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Elphinstone RE; Besla R; Shikatani EA; Lu Z; Hausladen A; Davies M; Robbins CS; Husain M; Stamler JS; Kain KC
    Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28674030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta interferon suppresses the development of experimental cerebral malaria.
    Morrell CN; Srivastava K; Swaim A; Lee MT; Chen J; Nagineni C; Hooks JJ; Detrick B
    Infect Immun; 2011 Apr; 79(4):1750-8. PubMed ID: 21245265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria.
    Brant F; Miranda AS; Esper L; Gualdrón-López M; Cisalpino D; de Souza DDG; Rachid MA; Tanowitz HB; Teixeira MM; Teixeira AL; Machado FS
    Brain Behav Immun; 2016 May; 54():73-85. PubMed ID: 26765997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protective effects of artesunate combination on experimental cerebral malaria and nerve injury].
    Jiang XH; Chen LN; Li K; Guo Y; Zheng ZY; Yang T; Zheng XJ; Li YJ; Zhu XX
    Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3051-3057. PubMed ID: 30200698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria.
    Campos AC; Brant F; Miranda AS; Machado FS; Teixeira AL
    Neuroscience; 2015 Mar; 289():166-80. PubMed ID: 25595981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.
    Solomon W; Wilson NO; Anderson L; Pitts S; Patrickson J; Liu M; Ford BD; Stiles JK
    J Neuroinflammation; 2014 Jan; 11():9. PubMed ID: 24433482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria.
    Wilson NO; Solomon W; Anderson L; Patrickson J; Pitts S; Bond V; Liu M; Stiles JK
    PLoS One; 2013; 8(4):e60898. PubMed ID: 23630573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model.
    Odhiambo OC; Wamakima HN; Magoma GN; Kirira PG; Malala BJ; Kimani FT; Muregi FW
    Malar J; 2017 Jul; 16(1):268. PubMed ID: 28673299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral artesunate prevents Plasmodium berghei Anka infection in mice.
    Gumede B; Folb P; Ryffel B
    Parasitol Int; 2003 Mar; 52(1):53-9. PubMed ID: 12543147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
    Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
    Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
    Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
    Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.